Quantitative evaluation of electroconvulsive therapy for Parkinson’s disease with refractory psychiatric symptoms

Journal of Neural Transmission

Volumn 121, Issue 11, 2014, Pages 1405-1410

  Nishioka, Kenya ^a   Tanaka, Ryota ^a   Shimura, Hideki ^b   Hirano, Kazuoki ^a   Hatano, Taku ^a   Miyakawa, Koichi ^b   Arai, Heii ^a   Hattori, Nobutaka ^a   Urabe, Takao ^b  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY URAYASU HOSPITAL   (Japan)

Author keywords

Catatonia; Depression; ECT; NPI score; Parkinson s disease

Indexed keywords

AMANTADINE; BENSERAZIDE PLUS LEVODOPA; BROMOCRIPTINE; CABERGOLINE; CARBIDOPA PLUS LEVODOPA; CLONAZEPAM; CLOXAZOLAM; DIAZEPAM; ENTACAPONE; LEVODOPA; MIANSERIN; PAROXETINE; PERGOLIDE; PRAMIPEXOLE; QUETIAPINE; ROPINIROLE; SELEGILINE; TRAZODONE; TRIHEXYPHENIDYL;

ADULT; AGED; AKINESIA; ALCOHOLISM; ANXIETY; ARTICLE; ASSESSMENT OF HUMANS; AUDITORY HALLUCINATION; BARTHEL INDEX; BECK DEPRESSION INVENTORY; CASE REPORT; CATATONIA; CLINICAL EVALUATION; DELUSION; DEPRESSION; DISEASE SEVERITY; DOMESTIC VIOLENCE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSTONIA; ELECTROCONVULSIVE THERAPY; FATIGUE; FEMALE; GAIT DISORDER; HAMILTON DEPRESSION RATING SCALE; HAND TREMOR; HEART PALPITATION; HOEHN AND YAHR SCALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; IMMOBILITY; INSOMNIA; LOSS OF APPETITE; MALE; MENTAL DISEASE; MIDDLE AGED; MINI MENTAL STATE EXAMINATION; MOOD DISORDER; MOTOR DYSFUNCTION; MUSCLE RIGIDITY; MUTISM; NEUROPSYCHIATRIC INVENTORY; PANIC; PARANOIA; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PSYCHIATRIST; PSYCHOSIS; QUANTITATIVE ANALYSIS; REVISED HASEGAWA DEMENTIA SCALE; STUPOR; SUICIDE ATTEMPT; UNIFIED PARKINSON DISEASE RATING SCALE; VISUAL HALLUCINATION; COMPLICATION; MOOD DISORDERS; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOTIC DISORDERS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

AGED; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; MOOD DISORDERS; PARKINSON DISEASE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84925719742     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-014-1212-4     Document Type: Article

References (28)

1. Aarsland D, Larsen JP, Waage O, Langeveld JH (1997) Maintenance electroconvulsive therapy for Parkinson's disease. Convuls Ther 13(4):274-277
2. Aarsland D, Bronnick K, Ehrt U, De Deyn PP, Tekin S, Emre M, Cummings JL (2007) Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress. J Neurol Neurosurg Psychiatry 78(1):36-42. doi:10.1136/jnnp.2005.083113
3. Aarsland D, Pahlhagen S, Ballard CG, Ehrt U, Svenningsson P (2012) Depression in Parkinson disease-epidemiology, mechanisms and management. Nat Rev Neurol 8(1):35-47. doi:10.1038/nrneurol. 2011.189
4. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561-571
5. Collin C, Wade DT, Davies S, Horne V (1988) The Barthel ADL index: a reliability study. Int Disabil Stud 10(2):61-63
6. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44(12):2308-2314
7. Faber R, Trimble MR (1991) Electroconvulsive therapy in Parkinson's disease and other movement disorders. Mov Disord 6(4):293-303. doi:10.1002/mds.870060405
8. Fregni F, Simon DK, Wu A, Pascual-Leone A (2005) Non-invasive brain stimulation for Parkinson's disease: a systematic review and meta-analysis of the literature. J Neurol Neurosurg Psychiatry 76(12):1614-1623. doi:10.1136/jnnp.2005.069849
9. Goetz CG, Stebbins GT (1995) Mortality and hallucinations in nursing home patients with advanced Parkinson's disease. Neurology 45(4):669-671
10. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez- Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N (2008) Movement disorder society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23(15):2129-2170. doi:10.1002/mds.22340
11. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17(5):427-442
12. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181-184
13. Kamigaichi R, Kubo S, Ishikawa K, Yokoyama K, Ogaki K, Usui C, Hatta K, Arai H, Mochizuki H, Hattori N (2009) Effective control of catatonia in Parkinson's disease by electroconvulsive therapy: a case report. Eur J Neurol 16(2):e6. doi:10.1111/j. 1468-1331.2008.02357.x
14. Kennedy R, Mittal D, O'Jile J (2003) Electroconvulsive therapy in movement disorders: an update. J Neuropsychiatry Clin Neurosci 15(4):407-421
15. Kim KW, Lee DY, Jhoo JH, Youn JC, Suh YJ, Jun YH, Seo EH, Woo JI (2005) Diagnostic accuracy of mini-mental status examination and revised hasegawa dementia scale for Alzheimer's disease. Dement Geriatr Cogn Disord 19(5-6):324-330. doi:10.1159/000084558
16. Leentjens AF, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE, Weintraub D, Sampaio C, Poewe W, Rascol O, Stebbins GT, Goetz CG (2008a) Anxiety rating scales in Parkinson's disease: critique and recommendations. Mov Disord 23(14):2015-2025. doi:10.1002/mds.22233
17. Leentjens AF, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE, Weintraub D, Sampaio C, Poewe W, Rascol O, Stebbins GT, Goetz CG (2008b) Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations. Mov Disord 23(14):2004-2014. doi:10.1002/mds.22229
18. Madsen TM, Treschow A, Bengzon J, Bolwig TG, Lindvall O, Tingstrom A (2000) Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry 47(12):1043-1049 (pii:S0006322300002286)
19. Moellentine C, Rummans T, Ahlskog JE, Harmsen WS, Suman VJ, O'Connor MK, Black JL, Pileggi T (1998) Effectiveness of ECT in patients with parkinsonism. J Neuropsychiatry Clin Neurosci 10(2):187-193
20. Pintor LP, Valldeoriola F, Fernandez-Egea E, Sanchez R, Rami L, Tolosa E, Muniz A, Marti MJ, Bernardo M (2012) Use of electroconvulsive therapy in Parkinson disease with residual axial symptoms partially unresponsive to L-dopa: a pilot study. J ECT 28(2):87-91. doi:10.1097/YCT.0b013e31823c98c0
21. Pridmore S, Pollard C (1996) Electroconvulsive therapy in Parkinson's disease: 30 month follow up. J Neurol Neurosurg Psychiatry 60(6):693
22. Ramos-Brieva J, Cordero-Villafafila A (1988) A new validation of the Hamilton Rating Scale for Depression. J Psychiatr Res 22(1):21-28
23. Raveendranathan D, Narayanaswamy JC, Reddi SV (2011) Response rate of catatonia to electroconvulsive therapy and its clinical correlates. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/ s00406-011-0285-4
24. Suzuki K, Awata S, Nakagawa K, Takano T, Matsuoka H (2006) Catatonic stupor during the course of Parkinson's disease resolved with electroconvulsive therapy. Mov Disord 21(1):123-124. doi:10.1002/mds.20749
25. Swartz CM (2006) Electroconvulsive therapy stimulus dose expressed as volume of seizure foci. J ECT 22(1):54-58 (pii:00124509- 200603000-00012)
26. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 25(15):2649-2653. doi:10. 1002/mds.23429
27. Ueda S, Koyama K, Okubo Y (2010) Marked improvement of psychotic symptoms after electroconvulsive therapy in Parkinson disease. J ECT 26(2):111-115. doi:10.1097/YCT. 0b013e3181c18a3d
28. Usui C, Hatta K, Doi N, Kubo S, Kamigaichi R, Nakanishi A, Nakamura H, Hattori N, Arai H (2011) Improvements in both psychosis and motor signs in Parkinson's disease, and changes in regional cerebral blood flow after electroconvulsive therapy. Prog Neuropsychopharmacol Biol Psychiatry 35(7):1704-1708. doi:10.1016/j.pnpbp.2011.05.003